EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The role of IGF1 in determining body composition in children and adolescents with growth hormone deficiency and those with idiopathic short stature

Hussein Zaitoon iD, Michal Yackobovitch-Gavan iD, Eyas Midlej, Adi Uretzky, Irina Laurian, Anna Dorfman, Hagar Interator, Yael Lebenthal iD, Avivit Brener iD

Endocrine · 14.08.2024 · 86 (3) · 1110-1120

DOI: 10.1007/s12020-024-03992-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Endocrine, online erschienen am 14.08.2024. Verfasst von Hussein Zaitoon und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Body Composition, Insulin-Like Growth Factor I, Human Growth Hormone, Growth Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Treatment with recombinant human growth hormone (rhGH) increases insulin growth factor-1 (IGF1) levels, therefore, monitoring both IGF1 and growth constitutes an acceptable parameter of therapeutic safety and efficacy. We aimed to investigate the relationship between IGF1 level and body composition in children and adolescents undergoing rhGH therapy for growth hormone deficiency (GHD) and idiopathic short stature (ISS).

Methods

This observational retrospective study included the bioimpedance analysis (BIA) reports ( n = 305) of 135 pediatric patients (age 5–18 years), 64 with GHD and 71 with ISS, conducted as part of routine clinic visits. Sociodemographic and clinical data were extracted from medical records. Generalized estimating equations linear models were used to explore the contributing factors for body composition components of fat percentage (FATP), appendicular skeletal muscle mass (ASMM) z-score, and muscle-to-fat ratio (MFR) z-score while adjusting for cumulative doses of rhGH.

Results

Subjects with GHD exhibited higher body mass index z-scores ( p < 0.001), higher FATP and truncal FATP scores, lower MFR z-score, and higher diastolic blood pressure percentiles than the ISS group ( p = 0.010, p = 0.027, p = 0.050, and p = 0.050, respectively). Female sex ( p < 0.001) and a GHD diagnosis ( p < 0.001), were major contributors to higher FATP scores; female sex ( p = 0.049) and ISS diagnosis ( p = 0.005) were major contributors to higher MFR z-scores; and female sex ( p < 0.001), older age ( p < 0.001) and higher insulin-like growth factor 1 z-scores ( p = 0.021) were major contributors to higher ASMM z-scores. Socioeconomic position and cumulative rhGH dose were not significant contributors to body composition parameters.

Conclusion

Children with GHD, including those undergoing rhGH treatment, may be at risk for increased adiposity and associated metabolic implications. Sex- and age-adjusted IGF1 levels were related to muscle mass but not to adiposity. Hence, rhGH treatment aimed at increasing IGF1 levels may alleviate these effects by promoting muscle growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body CompositionInsulin-Like Growth Factor IHuman Growth HormoneGrowth DisordersHumansMaleFemaleAdolescentChildRetrospective StudiesChild, PreschoolDwarfism, PituitaryBody Mass Index

Stichwörter der Autor:innen

bioelectrical impedance analysis (BIA)fat percentagemuscle massmuscle-to-fat ratiopediatric patientssex dimorphism

Substanzen

Insulin-Like Growth Factor IHuman Growth HormoneIGF1 protein, human

Autor:innen und Institutionen

  • The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. avivitb@tlvmc.gov.il.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. avivitb@tlvmc.gov.il.

ORCID-Profile: Hussein Zaitoon, Michal Yackobovitch-Gavan, Yael Lebenthal, Avivit Brener

Zitieren

APA

Zaitoon, H., Yackobovitch-Gavan, M., Midlej, E., Uretzky, A., Laurian, I., Dorfman, A., Interator, H., Lebenthal, Y., & Brener, A. (2024). The role of IGF1 in determining body composition in children and adolescents with growth hormone deficiency and those with idiopathic short stature. Endocrine, 86(3), 1110-1120. https://doi.org/10.1007/s12020-024-03992-0

Vancouver

Zaitoon H, Yackobovitch-Gavan M, Midlej E, Uretzky A, Laurian I, Dorfman A, et al. The role of IGF1 in determining body composition in children and adolescents with growth hormone deficiency and those with idiopathic short stature. Endocrine. 2024;86(3):1110-1120. doi:10.1007/s12020-024-03992-0

BibTeX
@article{Zaitoon2024,
  author = {Zaitoon, Hussein and Yackobovitch-Gavan, Michal and Midlej, Eyas and Uretzky, Adi and Laurian, Irina and Dorfman, Anna and Interator, Hagar and Lebenthal, Yael and Brener, Avivit},
  title = {The role of IGF1 in determining body composition in children and adolescents with growth hormone deficiency and those with idiopathic short stature},
  journal = {Endocrine},
  year = {2024},
  volume = {86},
  number = {3},
  pages = {1110--1120},
  doi = {10.1007/s12020-024-03992-0}
}
Kostenlos starten →